Genetic testing in spinocerebellar ataxias: Defining a clinical role

E. K. Tan, T. Ashizawa

Research output: Contribution to journalReview articlepeer-review

44 Scopus citations


Although genetic tests for known spinocerebellar ataxia (SCA) genes are increasingly available, their exact clinical role has received much less attention. Currently available DNA tests can define the genotypes of up to two thirds of patients with dominantly inherited SCAs. Certain characteristic clinical features and ethnic predilection of some of the SCA subtypes may help prioritize specific SCA gene testing. Available data on genotype-phenotype correlation suggest that currently available DNA tests cannot accurately predict age of onset or prognosis. Because of the mostly adult-onset symptoms and the absence of effective treatment, genetic counseling is essential for addressing ethical, social, legal, and psychological issues associated with SCA DNA testing.

Original languageEnglish (US)
Pages (from-to)191-195
Number of pages5
JournalArchives of neurology
Issue number2
StatePublished - 2001

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology


Dive into the research topics of 'Genetic testing in spinocerebellar ataxias: Defining a clinical role'. Together they form a unique fingerprint.

Cite this